Safety and Efficacy of Sonohysterosalpingography for the Evaluation of Infertility

Sponsor
Northwell Health (Other)
Overall Status
Completed
CT.gov ID
NCT03234569
Collaborator
(none)
27
1
1
25.1
1.1

Study Details

Study Description

Brief Summary

This pilot study is a collaborative effort between Northwell Health's Departments of Fertility and Radiology.The aim of this study is to evaluate the feasibility of the Sonohysterosalpingography (sonoHSG) for it to be determined as the standard of care. Additionally, it aims to improve the work up of infertility by integrating the examination of structural abnormalities of the Fallopian tubes and uterus into a single radiation free ultrasound guided procedure, the sonoHSG.

Condition or Disease Intervention/Treatment Phase
  • Procedure: sonoHSG
N/A

Detailed Description

This pilot study is a collaborative effort between Northwell Health Fertility and the Radiology Department to streamline the fertility evaluation process and reduce the burden of stress many fertility patients experience by eliminating an imaging examination which is painful and exposes the patient to potentially harmful radiation.

The aim of this study is to improve the workup of infertility by integrating the examination of structural abnormalities of the fallopian tubes and uterus into a single radiation-free ultrasound guided procedure, the sonohysterosalpingogram (sonoHSG). Confirmation of tubal patency is extremely important as approximately 25-35% of female infertility can be attributed to fallopian tube pathology. The current paradigm is to use two separate imaging exams; the hysterosalpingogram (HSG), a transvaginal procedure that uses radiation and iodinated contrast to visualize the fallopian tubes, and the sonohysterogram, a transvaginal procedure that uses ultrasound and saline to visualize the uterus. By using agitated saline, to produce air bubbles, fallopian tube visualization is optimized during the time of sonohysterogram (sonoHSG). The investigators plan to also utilize a continuous saline-air device that may produce a technically superior sonoHSG.

As a result of this study, the Radiology Department and Northwell Health Fertility will work together to encourage, educate, and support physicians to promote the utility of sonoHSG as the first imaging examination for the infertility workup. Currently, this institution is not routinely utilizing the sonoHSG despite the advantages in safety, comfort, and convenience to the patient. The investigators aim to effect a change in the current practice at this institution by increasing the knowledge and visibility of the sonoHSG by creating educational materials for referring physicians, and creating a pilot program that demonstrates the value and efficacy of the exam. SonoHSG can be performed concurrently at the time of the sonohysterogram at no additional cost to the patient.

The investigators will enroll 30 patients from Northwell Health Fertility over the course of one year. Measures of success will include concordance between sonoHSG and HSG in patients who receive both procedures, and patient surveys evaluating pain utilizing the pain scale. If sonoHSG proves to be efficacious, future steps will be to educate referring physicians and patients about the utility of the examination using print materials and a grand rounds lecture. The investigators will also measure the number of sonoHSGs ordered compared to HSGs for the evaluation of fallopian tube patency in order to evaluate if there has been a shift in the standard of care.

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Safety and Efficacy of Sonohysterosalpingography for the Evaluation of Infertility
Actual Study Start Date :
Jan 31, 2018
Actual Primary Completion Date :
Mar 5, 2020
Actual Study Completion Date :
Mar 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: sonoHSG

This is the research procedure and it will be added onto the standard of care procedure for all subjects.

Procedure: sonoHSG
This procedure uses agitated saline to produce air bubbles at the time of the Sonohysterogram which optimizes fallopian tube visualization. The sonoHSG is free of radiation and use of contrast. In this study, in order to produce the air bubbles at the time of the sonohysterogram, the investigators will be using a continuous saline-air device that may produce a technically superior image. For the ultrasound images, General Electric will be supporting us by providing us the Voluson E10 and RIC5-9-D.

Outcome Measures

Primary Outcome Measures

  1. Concordance between sonoHSG and HSG results. The sonoHSG and HSG will be considered interchangeable if the level of agreement between them is >= 80%. [1 year]

Secondary Outcome Measures

  1. Quantification of level of patient pain in regard to sonoHSG versus HSG [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Undergoing evaluation for infertility in the Northwell Health System

  • Non-pregnant women age 18-50 years old

  • Subject is not menstruating at the time of study

  • Provide written informed consent and written HIPAA authorization prior to study initiation

  • Willing to comply with the specified follow-up evaluation schedule

Exclusion Criteria:
  • History of active pelvic infection

  • History of tubal ligation or salpingectomy

  • History of adverse reaction to iodinated contrast

  • Subject is pregnant

  • Subject is menstruating at time of study

  • Subject is unable to participate in study evaluations pre- and post-treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Northwell Health- North Shore University Hospital Manhasset New York United States 11030

Sponsors and Collaborators

  • Northwell Health

Investigators

  • Principal Investigator: John Pellerito, MD, Northwell Health

Study Documents (Full-Text)

More Information

Additional Information:

Publications

Responsible Party:
John Pellerito, Vice Chair, Education Department of Radiology, Northwell Health
ClinicalTrials.gov Identifier:
NCT03234569
Other Study ID Numbers:
  • 16-0967
First Posted:
Jul 31, 2017
Last Update Posted:
Apr 7, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by John Pellerito, Vice Chair, Education Department of Radiology, Northwell Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 7, 2022